Clinical Trials List
2022-08-31 - 2031-02-28
Phase III
Recruiting9
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
Co-Principal Investigator
- Tsung-Jang Yeh Division of Hematology & Oncology
- 蘇昶瑋 Division of Oral and Maxillofacial Surgery
- Chih-Jen Huang Division of Radiation Therapy
- Tzu-Yen Huang Division of Otolaryngology
- 許經偉 未分科
- 王緒佳 Division of Otolaryngology
- 林裕 未分科
- 曾良鵬 Division of Otolaryngology
- 高郁勛 Division of Oral and Maxillofacial Surgery
- 莊舒婷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉建廷 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 李易濰 Division of Radiology
- 林偉哲 Division of Hematology & Oncology
- 陳彥仰 未分科
- 陳彥豪 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- Jen-Yu Cheng Division of Radiation Therapy
- Shau-Hsuan Li Division of Hematology & Oncology
- 黃泰霖 Division of Hematology & Oncology
- 陳秉聰 未分科
- 蘇彥燁 Division of Otolaryngology
- Yu-Li Su Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 黃永成 未分科
- 方富民 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 葉智華 未分科
- 黃祥富 Division of Otolaryngology
- 鄭乃銘 Division of Nuclear Medicine
- Hung-Ming Wang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mu-Hsin Chang 未分科
- 黃品逸 Division of Hematology & Oncology
- 戴世光 Division of Otolaryngology
- Tien-Hua Chen Division of Hematology & Oncology
- Yuan-Hung Wu Division of Hematology & Oncology
- Chia-Fan Chang Division of Otolaryngology
- Ling-Wei Wang Division of Hematology & Oncology
- 朱本元 Division of Otolaryngology
- 胡育文 Division of Hematology & Oncology
- Tsung-Lun Lee Division of Otolaryngology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching Yun Hsieh 未分科
- Yao-Ching Wang Division of Radiation Therapy
- Chun-Hung Hua Division of Otolaryngology
- Shih-Neng Yang 未分科
- Yu-Min Liao Division of Hematology & Oncology
- Ying-Chun Lin Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蔡巧琳 Division of Hematology & Oncology
- HUAI-CHENG HUANG Division of Hematology & Oncology
- 陳婉瑜 Division of Hematology & Oncology
- 賴詩璠
- 王駿瑋 Division of Hematology & Oncology
- YA-FANG CHEN Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
700 participants
